Company page
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. (SGMO) is a public biotechnology company based in the United States, focused on developing genomic therapies for various diseases. The company utilizes its proprietary technology platforms to create innovative treatments aimed at addressing unmet medical needs. Sangamo is committed to advancing its pipeline of product candidates through research and development efforts.

- Ticker
- SGMO:NASDAQ
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD